Iam Advisory, LLC Bristol Myers Squibb CO Transaction History

Iam Advisory, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$63.71 - $70.74 $87,282 - $96,913	1,370 Added 7.33%	20,063 $1.28 Million
Q1 2023 Apr 10, 2023	BUY	$65.71 - $74.53 $135,822 - $154,053	2,067 Added 12.43%	18,693 $1.3 Million
Q4 2022 Jan 17, 2023	BUY	$68.48 - $81.09 $55,742 - $66,007	814 Added 5.15%	16,626 $0
Q3 2022 Oct 17, 2022	BUY	$0.13 - $76.84 $185 - $109,650	1,427 Added 9.92%	15,812 $1.12 Million
Q2 2022 Jul 12, 2022	BUY	$72.62 - $79.98 $40,376 - $44,468	556 Added 4.02%	14,385 $1.11 Million
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $35,904 - $43,052	584 Added 4.41%	13,829 $1.01 Million
Q4 2021 Jan 19, 2022	BUY	$53.63 - $62.52 $87,524 - $102,032	1,632 Added 14.05%	13,245 $862,000
Q3 2021 Oct 14, 2021	BUY	$59.17 - $69.31 $687,141 - $804,897	11,613 New	11,613 $667,000
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $650,302 - $708,179	-10,504 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $19,404 - $21,823	327 Added 3.21%	10,504 $667,000
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $587,619 - $665,881	10,177 New	10,177 $631,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Iam Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Iam Advisory, LLC with notifications on news.